Bittensor has introduced a proposal for Gamma tokens, a new economic layer allowing its subnets to trade compute and inference services using credits backed by their own TAO emissions. This shifts TAO from being solely a reward token to also serving as an operational currency, encouraging collaboration rather than competition among subnets. The network, which supports over 100 specialized AI markets, aims to enhance overall capability by enabling subnets to reinvest emissions into services rather than liquidate them. The proposal is still conceptual, with key details on token mechanics and governance yet to be finalized, and the implementation timeline remains uncertain.
Bittensor's proposal for Gamma tokens is presented here with Pluang's market data for context. As of Sep 29, 2026 02:51 WIB, out of 50 major cryptocurrencies on Pluang, 10 rose and 39 fell. Notable price changes include BCH at Rp5.517.177 with a -8.28% change and 82% sell order activity, ATOM at Rp31.045 with a -8.13% change, and EOS at Rp12.649 with an 8.13% increase.
Morgan Stanley raised the price target for Reinsurance Group of America (RGA) to $295, implying a 16.7% upside from its current price of $252.85. The company reported a 42% increase in adjusted operating income to $746 million in H1, driven by its lo...
H.C. Wainwright raised Mirum Pharmaceuticals' price target from $140 to $195 following positive developments: the Phase 3 AZURE-1 trial for Brelovitug met its main goal for treating Chronic Hepatitis Delta Virus, and the FDA approved Atebrioz™ for Fi...
Kodiak Sciences reported successful Phase 3 trial results for its retinal disease treatments Zenkuda and tabirafusp-ted, showing vision improvements comparable to Regeneron's Eylea. Zenkuda allowed 54% of patients to maintain a six-month dosing inter...
Citigroup has maintained a Neutral rating on Regeneron Pharmaceuticals due to increasing competition in the ophthalmology sector. Kodiak Sciences reported positive Phase 3 trial results for its eye drugs, challenging Regeneron's key product, Eylea, e...
Micromem Technologies Inc. has decided to adopt semi-annual financial reporting, discontinuing quarterly interim reports to reduce administrative costs. The company will now report financial results twice a year, for the fiscal year ending October 31...
